Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and conventional brachytherapy: in vitro study

Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and conventional brachytherapy: in vitro study

Elham Shahhoseini,1 Prabhakar Ramachandran,1,2 William Roy Patterson,3 Moshi Geso1 1Discipline of Medical Radiation, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia; 2Department of Physical Sciences, Peter Mac Callum Cancer Centre, Melbourne, VIC, Australia; 3And...

Full description

Bibliographic Details
Main Authors: Shahhoseini E, Ramachandran P, Patterson WR, Geso M
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:International Journal of Nanomedicine
Subjects:
Keywords: Gold nanoparticles
Prostate cancer cells
lung cancer cells
Xoft® Axxent®Electronic Brachytherapy (eBxTM)
192Ir brachytherapy
Dose enhancement factor.
Online Access:https://www.dovepress.com/determination-of-dose-enhancement-caused-by-aunps-with-xoftreg-axxentr-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/determination-of-dose-enhancement-caused-by-aunps-with-xoftreg-axxentr-peer-reviewed-article-IJN

Similar Items